Skip to content

Genetic Analysis of Congenital Diaphragmatic Disorders

Genetic Analysis of Congenital Diaphragmatic Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01243229
Enrollment
305
Registered
2010-11-18
Start date
2010-10-31
Completion date
2021-06-01
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Diaphragmatic Disorders, Congenital Diaphragmatic Eventration, Congenital Diaphragmatic Hernia, Congenital Hiatal Hernia

Brief summary

The purpose of this study is to understand the genetic causes of congenital diaphragmatic disorders (CDD), namely congenital diaphragmatic hernia (CDH), eventration and hiatal hernia. Specifically, the investigators plan to: 1. Ascertain informative families and sporadic cases with congenital diaphragmatic disorders and obtain appropriate phenotypic data and genetic material (peripheral blood and/or diaphragm tissue sample). 2. Localize the gene(s) for CDD to specific chromosomal segments using linkage analysis, and determine the role of somatic mutations in CDD. 3. Isolate and characterize genes involved in the pathogenesis of CDD. 4. Develop molecular markers that will facilitate accurate diagnosis (including prenatal diagnosis) and permit correlation of phenotypic variation with specific mutations. 5. Compare RNA-sequencing from tissue samples of children without CDH to those children with CDH.

Interventions

None listed

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with a congenital diaphragmatic disorder

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Genes implicated in CDD can be identified by linkage analysis5 yearsUsing the Utah Population Database, genes implicated in CDD can be identified by linkage analysis

Secondary

MeasureTime frameDescription
Develop molecular markers that will facilitate accurate diagnosis of CDD and CDH.5 yearsDevelop molecular markers that will facilitate accurate diagnosis (including prenatal diagnosis) and permit correlation of phenotypic variation with specific mutations by localizing the gene(s) for CDH to specific chromosomal segments using linkage analysis in familial cases. In sporadic cases, characterize the role of somatic mutations in CDDs by using a candidate gene approach, and comparative genomic hybridization (CGH) arrays.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026